Contraindicated in:
Use Cautiously in:
CV: MYOCARDITIS, HF, MI, hypertension, peripheral edema, pericarditis, vasculitis.
Derm: DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, pruritus, rash.
EENT: iritis, uveitis.
Endo: ADRENAL INSUFFICIENCY, hypothyroidism, hyperthyroidism, hypoparathyroidism, hypophysitis, type 1 diabetes.
F and E: hyponatremia, hyperkalemia.
GI: COLITIS, HEPATITIS, abdominal pain, constipation, ↓appetite, diarrhea, ↑lipase, ↑liver enzymes, nausea, vomiting, gastritis, ↑ amylase, pancreatitis.
GU: urinary tract infection, nephritis.
Hemat: anemia, lymphopenia, thrombocytopenia, hemolytic anemia, neutropenia.
Metab: ↓weight.
MS: RHABDOMYOLYSIS, pain, myositis.
Neuro: autoimmune neuropathy, Guillain-Barré syndrome, myasthenic syndrome, myelitis , ENCEPHALITIS, MENINGITIS, dizziness, headache.
Resp: PNEUMONITIS, cough, dyspnea, fever.
Misc: infusion-related reactions, fatigue.
MCC
Urothelial Carcinoma and RCC
Absorption: IV administration results in complete bioavailability.
Distribution: Minimally distributed to tissues.
Metabolism/Excretion: Primarily eliminated via proteolytic degradation.
Half-life: 6.1 days.
NDC Code*